Xue, Peng
Johns Hopkins University · Johns Hopkins Medicine · Third Hospital of Hebei Medical University
4 papers on CoChatORCID 0000-0003-2449-2815
Most cited papers
- Verified
Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin
Wu, X., Li, S., Xue, P., & Li, Y. (2017) · Experimental Cell Research
Bone Metabolism and DiseasesWnt/β-catenin signaling in development and cancer
Cited by 92
- Verified
PGE2/EP4 skeleton interoception activity reduces vertebral endplate porosity and spinal pain with low-dose celecoxib
Xue, P., Wang, S., Lyu, X., Wan, M., Li, X., Ma, L., Ford, N. C., Li, Y., Guan, Y., Ding, W., et al. (2021) · Bone Research
Spine and Intervertebral Disc PathologyPain Mechanisms and Treatments
Cited by 64
- Verified
Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease
Wong, S.-W., Huang, B.-W., Hu, X., Ho Kim, E., Kolb, J. P., Padilla, R. J., Xue, P., Wang, L., Oguin, T. H., Miguez, P. A., et al. (2020) · Cell Death & Differentiation
Bone Metabolism and DiseasesOsteomyelitis and Bone Disorders Research
Cited by 42
- Verified
Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system
Li, L.-Q., Yao, M.-Y., Ma, J.-X., Xue, P., & Li, Y.-K. (2019) · Endocrine Journal
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free